Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-24 MORRISSEY MICHAEL President and CEO Gift +67,374 1,059,683
2021-02-24 COHEN CHARLES Director Exercise or conversion +40,000 $3.38 $135K 221,375
2021-02-24 COHEN CHARLES Director Sale −40,000 $22.69 $908K 181,375
2021-02-24 COHEN CHARLES Director Exercise or conversion · Option (right to buy) −40,000 0
2021-02-23 WILLSEY LANCE Director Exercise or conversion +40,000 $3.38 $135K 464,415
2021-02-23 WILLSEY LANCE Director Sale −39,200 $21.92 $859K 425,215
2021-02-23 WILLSEY LANCE Director Sale −800 $22.34 $18K 424,415
2021-02-23 WILLSEY LANCE Director Exercise or conversion · Option (right to buy) −40,000 0
2021-02-22 POSTE GEORGE Director Exercise or conversion +40,000 $3.38 $135K 197,992
2021-02-22 POSTE GEORGE Director Exercise or conversion · Option (right to buy) −40,000 0
2021-02-22 MARCHESI VINCENT T Director Sale −24,097 $22.29 $537K 66,115
2021-02-18 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +50,000 $1.70 $85K 590,597
2021-02-18 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Sale −50,000 $22.35 $1.1M 540,597
2021-02-18 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −50,000 100,000
2021-02-17 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +50,000 $1.70 $85K 590,597
2021-02-17 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Sale −50,000 $22.50 $1.1M 540,597
2021-02-17 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −50,000 150,000
2021-02-16 WILLSEY LANCE Director Sale −50,000 $21.90 $1.1M 424,415
2021-02-16 FELDBAUM CARL B Director Exercise or conversion +20,000 $3.38 $68K 28,521
2021-02-16 FELDBAUM CARL B Director Sale −20,000 $21.96 $439K 8,521

Page 35 of 42 · 836 trades